---
title: "SDIC Securities Reaffirms Their Buy Rating on China Resources Beverage (Holdings) Company Limited (2460)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287429148.md"
description: "SDIC Securities has reaffirmed a Buy rating on China Resources Beverage (Holdings) Company Limited, setting a price target of HK$10.45. The shares closed at HK$8.09, with a Strong Buy consensus rating and an average price target of HK$12.40."
datetime: "2026-05-23T05:19:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287429148.md)
  - [en](https://longbridge.com/en/news/287429148.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287429148.md)
generator: "portal-rs"
---

# SDIC Securities Reaffirms Their Buy Rating on China Resources Beverage (Holdings) Company Limited (2460)

SDIC Securities analyst maintained a Buy rating on China Resources Beverage (Holdings) Company Limited yesterday and set a price target of HK$10.45. The company’s shares closed yesterday at HK$8.09.

### Meet Samuel – Your Personal Investing Prophet

-   Start a conversation with TipRanks’ trusted, data-backed investment intelligence
-   Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds

The word on The Street in general, suggests a Strong Buy analyst consensus rating for China Resources Beverage (Holdings) Company Limited with a HK$12.40 average price target.

### Related Stocks

- [02460.HK](https://longbridge.com/en/quote/02460.HK.md)

## Related News & Research

- [China Resources Beverage (Holdings) Company Limited (2460) Gets a Buy from CICC](https://longbridge.com/en/news/291023660.md)
- [China Resources Beverage (Holdings) Company Limited (2460) Gets a Buy from Huatai Securities](https://longbridge.com/en/news/280864985.md)
- [Lowe’s Earns Buy Rating as Strong Earnings and Cash Generation Offset Lower-End Guidance](https://longbridge.com/en/news/296383656.md)
- [Analyst Reiterates Buy on Cogent Biosciences, Maintains $55 Price Target Amid Late-Stage Pipeline and Strong Cash Position](https://longbridge.com/en/news/296384188.md)
- [Avricore Health’s HealthTab signs multi-year collaboration with Abbott for UK point-of-care testing distribution](https://longbridge.com/en/news/296474749.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**